BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 28425245)

  • 1. Predictive assessment in pharmacogenetics of Glutathione S-transferases genes on efficacy of platinum-based chemotherapy in non-small cell lung cancer patients.
    Ye H; Shao M; Shi X; Wu L; Xu B; Qu Q; Qu J
    Sci Rep; 2017 Jun; 7(1):2670. PubMed ID: 28572675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive potential role of GSTs gene polymorphisms in the treatment outcome of advanced non-small cell lung cancer patients.
    Liu K; Lin Q; Ding H; Jin Y; Chen G
    Int J Clin Exp Med; 2015; 8(11):20918-24. PubMed ID: 26885019
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Vieira JO; Pesquero JB; Nazário ACP
    Breast Care (Basel); 2024 Apr; 19(2):96-105. PubMed ID: 38765899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione S‑transferase ω 1 promotes the proliferation, migration and invasion, and inhibits the apoptosis of non‑small cell lung cancer cells, via the JAK/STAT3 signaling pathway.
    Wang K; Zhang FL; Jia W
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome P-450 Polymorphisms and Clinical Outcome in Patients with Non-Small Cell Lung Cancer.
    Işcan M; Ada AO
    Turk J Pharm Sci; 2017 Dec; 14(3):319-323. PubMed ID: 32454631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP53 mutations in nonsmall cell lung cancer.
    Mogi A; Kuwano H
    J Biomed Biotechnol; 2011; 2011():583929. PubMed ID: 21331359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between the TP53 and CYP2E1*5B gene polymorphisms and non-small cell lung cancer.
    Ada AO; Bilgen S; Karacaoglan V; Kunak CS; Soydas E; Alpar S; Gulhan M; Iscan M
    Arh Hig Rada Toksikol; 2016 Dec; 67(4):311-316. PubMed ID: 28033105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of GSTs gene polymorphisms with treatment outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy.
    Wu G; Jiang B; Liu X; Shen Y; Yang S
    Int J Clin Exp Pathol; 2015; 8(10):13346-52. PubMed ID: 26722539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between glutathione S-transferase pi polymorphisms and survival in patients with advanced nonsmall cell lung carcinoma.
    Lu C; Spitz MR; Zhao H; Dong Q; Truong M; Chang JY; Blumenschein GR; Hong WK; Wu X
    Cancer; 2006 Jan; 106(2):441-7. PubMed ID: 16342067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP and GST polymorphisms and survival in advanced non-small cell lung cancer patients.
    Ada AO; C Kunak S; Hancer F; Bilgen S; Suzen SH; Alpar S; Gulhan M; Kurt B; Iscan M
    Neoplasma; 2010; 57(6):512-21. PubMed ID: 20845989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between the genetic polymorphisms of phase I and II drug-metabolizing enzymes, as well as the outcome of chemotherapy in advanced non-small cell lung cancer].
    Li W; Yue W; Yang X; Zhang C; Wang Y
    Zhongguo Fei Ai Za Zhi; 2011 Nov; 14(11):858-64. PubMed ID: 22104220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xenobiotic/drug metabolizing enzyme and TP53 polymorphisms and clinical outcome in advanced nonsmall cell lung cancer patients.
    Karacaoğlan V; Ada AO; Bilgen S; Çetinkaya GT; Soydaş E; Kunak CS; Alpar SM; Gülhan M; Işcan M
    Turk J Med Sci; 2017 Apr; 47(2):554-562. PubMed ID: 28425245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis.
    Matakidou A; Eisen T; Houlston RS
    Mutagenesis; 2003 Jul; 18(4):377-85. PubMed ID: 12840112
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.